
Charles Ryan Hattemer, MD
Professor of Clinical
Division Chief of Cardiovascular Health and Disease; Mabel Stearns Stonehill Endowed Chair
Medical Science Building
231 Albert Sabin Way, MLC 0542
Cincinnati, Ohio 45267
Phone 513-558-2307
Email charles.hattemer@uc.edu
Professional Summary
Professor of Medicine
Education
Medical Degree: Case Western Reserve University School of Medicine Cleveland, OH, 1985
Internal Medicine Residency: University of Cincinnati College of Medicine Cincinnati, OH, 1989
Cardiovascular Disease Fellowship: University of Cincinnati College of Medicine Cincinnati, OH, 1993
Undergraduate Degree: Harvard University Cambridge, MA, 1981 (Bachelor's of Arts)
Certifications
American Board of Internal Medicine (Certification Date: 09-13-1989 )
American Board of Internal Medicine (Cardiovascular Disease) (Certification Date: 11-04-1993 ) - (Recertification Date: to 07-23-2024 )
Clinical Interests
Cardiology
Cardiology Interventional
Cardiovascular Disease
Internal Medicine
Specialities
Cardiovascular Disease
Internal Medicine
Publications
Peer Reviewed Publications
Dippel, E J; Kereiakes, D J; Tramuta, D A; Broderick, T M; Shimshak, T M; Roth, E M; Hattemer, C R; Runyon, J P; Whang, D D; Schneider, J F; Abbottsmith, C W (2001). Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 52 (3) , 279-86More Information
Kereiakes, D J; Obenchain, R L; Barber, B L; Smith, A; McDonald, M; Broderick, T M; Runyon, J P; Shimshak, T M; Schneider, J F; Hattemer, C R; Roth, E M; Whang, D D; Cocks, D; Abbottsmith, C W (2000). Abciximab provides cost-effective survival advantage in high-volume interventional practice. American heart journal, 140 (4) , 603-10More Information
Kereiakes, D J; Broderick, T M; Roth, E M; Whang, D; Shimshak, T; Runyon, J P; Hattemer, C; Schneider, J; Lacock, P; Mueller, M; Abbottsmith, C W (1999). Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. The American journal of cardiology, 84 (4) , 391-5
Ritchie, M E; Hattemer, C; Lenihan, D (1998). Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease. Cardiology, 89 (1) , 76-8
Gibler, W B; Runyon, J P; Levy, R C; Sayre, M R; Kacich, R; Hattemer, C R; Hamilton, C; Gerlach, J W; Walsh, R A (1995). A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Annals of emergency medicine, 25 (1) , 1-8
Yingling, K W; Hattemer, C; Rouan, G W; Luke, R G (1991). Internal medicine residents' monitoring of their colleagues' moonlighting activities at the University of Cincinnati. Academic medicine : journal of the Association of American Medical Colleges, 66 (11) , 705-6
Contact Information
Academic - Medical Science Building
231 Albert Sabin Way, MLC 0542
Cincinnati
Ohio, 45267
Phone: 513-558-2307
charles.hattemer@uc.edu